Faron, etusivu

releases and announcements

Ex Vivo Data Presented at EHA2022 Congress

Mol Cancer Ther Publishes Bexmarilimab Research

Grant of options

Insider Transaction Regulatory

Board Changes

Regulatory

Results of the AGM

Regulatory

Faron Presents Results from Melanoma Cohort of MATINS Trial at 18[th] Congress of the European Association of Dermato-Oncology (EADO)

Managers’ Transactions

Insider Transaction Regulatory

Faron Closes HIBISCUS Trial

Regulatory

Notice of Faron Pharmaceuticals Ltd’s AGM

Regulatory

Faron´s Annual Report 2021 Published

Regulatory
PreviousNext
Back to top